Linked Life Data

20123204

Source:http://linkedlifedata.com/resource/pubmed/id/20123204

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-2-3
pubmed:abstractText
Hypercholesterolemia is an important and easily modifiable risk factor for peripheral arterial disease (PAD), but is frequently not adequately addressed by vascular interventionists. Patients with PAD often have extensive atherosclerotic disease elsewhere and have a 1-year mortality rate as high as 20%, mainly from cardiovascular events. This case discussion briefly addresses the evidence for treating hypercholesterolemia in this subgroup of patients. Statins not only lower cholesterol, but also are antiinflammatory, antiproliferative, and antithrombogenic, and improve endothelial function. Current guidelines are reviewed and an approach to initiation of statins and their management is discussed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1535-7732
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2010 SIR. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
175-7, quiz 178
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Statin prescription is essential in peripheral vascular disease.
pubmed:affiliation
Department of Radiology, Sandwell and West Birmingham Hospitals National Health Service Trust, Lyndon, West Bromwich, West Midlands B71 4HJ, UK. joe.leyon@swbh.nhs.uk
pubmed:publicationType
Journal Article, Review, Case Reports